The U.S. Supreme Court ruled Tuesday that a decision could affect how women can obtain mifepristone, one of two pills used in the most common type of abortion in the United States. We plan to take up the lawsuit.
A central issue in the case is whether the Food and Drug Administration overlooked serious safety concerns when it made mifepristone more available through mail-order pharmacies and other outlets.
Legal briefs filed with the court describe the pill’s safety in very different terms. Medical experts have called the pill “one of the safest drugs” the FDA has ever approved, while a Christian conservative group suing the FDA claims it has been used in “tens of thousands” of “emergency cases.” The cause is “complications”. For medicine.
Ahead of landmark Scotus case, major drugstores begin selling abortion pills that some say are ‘dangerous’ for women
Earlier this year, a medical journal retracted two studies that claimed to show mifepristone’s harm. This study was cited in a pivotal Texas court decision that brought this issue to the Supreme Court. The publisher cited the authors’ conflicts of interest and flaws in the study, but the study’s lead author called the retraction a baseless attack.
A box of the drug mifepristone sits on a shelf at the West Alabama Women’s Center on March 16, 2022 in Tuscaloosa, Alabama. On Tuesday, March 26, 2024, the U.S. Supreme Court will take up a case that could impact women’s health. Her access to mifepristone, one of two types of pills used in the most common type of abortion in the country. (AP Photo/Allen G. Breed)
Here’s what you need to know about the safety of mifepristone, which is commonly used with misoprostol in medication abortions.
What safety restrictions has the FDA imposed since 2000?
The FDA approved mifepristone in 2000 as a safe and effective way to end early pregnancies.
In rare cases, mifepristone can cause dangerous excessive bleeding that requires emergency treatment. As a result, the FDA has placed strict safety restrictions on who can prescribe and distribute the drug. Only specially certified physicians and only as part of her three mandatory in-person appointments with patients receiving medication.
Doctors also needed the ability to perform emergency surgeries to stop excessive bleeding and abortion procedures if drugs did not terminate the pregnancy.
Over the years, the FDA has reaffirmed mifepristone’s safety and repeatedly eased restrictions, culminating in a 2021 decision to eliminate the in-person requirement and allow pills to be mailed.
How often do serious problems occur?
Abortion opponents say the loosening of regulations has led to more “emergency complications.” But this discussion lumps together women who experience a range of problems with mifepristone, from those for whom the drug doesn’t work to those who simply have questions or concerns and don’t seek medical care.
Obstetricians and gynecologists say a small proportion of patients experience “serious” or “severe” adverse events after taking mifepristone.
A legal brief by a group of medical organizations, including the American College of Obstetricians and Gynecologists, says, “When used in medical abortions, serious adverse events, including serious infections, excessive blood loss, and hospitalization, occur in 0.32% of patients. “occurs in less than Contributed to highly acclaimed research involving over 50,000 patients. ”
Ushma Upadhyay, one of the authors of the 2015 study, said the definition scientists commonly use for serious adverse events includes blood transfusions, major surgery, hospitalization, and death. He added: “This hospitalization encompasses a very serious but rarer set of events, such as a major outbreak.”
The prescribing information on the package of mifepristone tablets provides slightly different statistics regarding so-called “serious side effects.” It lists a range of how often different complications occur: 0.03% to 0.5% for blood transfusions; 0.2% for sepsis and 0.04% to 0.6% for medical abortion-related hospitalizations. Experts say this range reflects the results of a variety of related studies.
Why do patients go to the emergency room?
Mifepristone’s label also lists complications that most medical communities do not consider to be serious or significant adverse events, namely emergency department visits, which range from 2.9% to 4.6%. Ta. The current FDA label states that a visit to the ER is an option if a patient experiences prolonged heavy bleeding, severe abdominal pain, or persistent fever.
But doctors told The Associated Press that ER visits don’t always reflect a larger problem.
Upadhyay, a professor at the University of California, San Francisco, said some people may come to the hospital after a medical abortion because they want to undergo tests or have questions but no doctor is available. says. She says some people “don’t want to talk to their doctor about abortion” because of the stigma.
A study she co-authored in 2018 found that just over half of patients who visited the ER for an abortion received only observation. Upadhyay said some of her patients “haven’t received any treatment at all.”
How effective are the pills?
Mifepristone completes abortion 97.4% of the time, according to a U.S. study cited on the FDA label.
However, 2.6% of cases require surgical intervention. And the chance of the pregnancy continuing is 0.7%.
This compares to in-clinic abortions, which have a “very, very low chance” of not terminating the pregnancy, perhaps less than 0.1 percent, said Dr. Pratima Gupta, director of the American College of Obstetricians. And a gynecologist.
“Whenever a surgical abortion is performed, the clinician may examine the removed tissue or perform an ultrasound during or after the procedure to ensure it was a complete abortion.” she said.
Dr. Gupta, who has been performing abortions for more than 20 years, said, “There are very few complications from abortion, whether it is abortion, medication, or type of abortion procedure.” Recent research suggests that this is equally true for medical abortions performed in clinics, clinics, or at home with the help of telemedicine.
How does mifepristone’s safety and effectiveness compare to other drugs?
The FDA makes drug approval decisions on a case-by-case basis, weighing efficacy, safety, and other factors.
No drug is 100% effective, and many common drugs are ineffective for a large proportion of patients.
Antidepressants typically help 40% to 60% of people with depression. New antibiotics approved by the FDA often resolve about 70% of infections.
CLICK HERE TO GET THE FOX NEWS APP
According to the FDA, approximately 6 million patients have taken mifepristone since 2000. A review of government records in 2021 for deaths likely related to the drug identified 13 deaths, or 0.00027% of patients.
Medical organizations supporting mifepristone’s availability say that when mortality rates are taken into account, the drug’s safety is comparable to “ibuprofen, which more than 30 million Americans take daily.”
